Back to Search Start Over

SP1 and NFY Regulate the Expression of PNPT1 , a Gene Encoding a Mitochondrial Protein Involved in Cancer.

Authors :
Ventura I
Revert F
Revert-Ros F
Gómez-Tatay L
Prieto-Ruiz JA
Hernández-Andreu JM
Source :
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 27; Vol. 23 (19). Date of Electronic Publication: 2022 Sep 27.
Publication Year :
2022

Abstract

The Polyribonucleotide nucleotidyltransferase 1 gene ( PNPT1 ) encodes polynucleotide phosphorylase (PNPase), a 3'-5' exoribonuclease involved in mitochondrial RNA degradation and surveillance and RNA import into the mitochondrion. Here, we have characterized the PNPT1 promoter by in silico analysis, luciferase reporter assays, electrophoretic mobility shift assays (EMSA), chromatin immunoprecipitation (ChIP), siRNA-based mRNA silencing and RT-qPCR. We show that the Specificity protein 1 (SP1) transcription factor and Nuclear transcription factor Y (NFY) bind the PNPT1 promoter, and have a relevant role regulating the promoter activity, PNPT1 expression, and mitochondrial activity. We also found in Kaplan-Meier survival curves that a high expression of either PNPase, SP1 or NFY subunit A (NFYA) is associated with a poor prognosis in liver cancer. In summary, our results show the relevance of SP1 and NFY in PNPT1 expression, and point to SP1/NFY and PNPase as possible targets in anti-cancer therapy.

Details

Language :
English
ISSN :
1422-0067
Volume :
23
Issue :
19
Database :
MEDLINE
Journal :
International journal of molecular sciences
Publication Type :
Academic Journal
Accession number :
36232701
Full Text :
https://doi.org/10.3390/ijms231911399